1cP-MIPLA
外觀
| 臨床資料 | |
|---|---|
| 其他名稱 | 1cP-MiPLA; 1-Cyclopropanoyl-MIPLA; 1-Cyclopropanoyl-N-methyl-N-isopropyllysergamide; 1-(Cyclopropanecarbonyl)-N,6-dimethyl-N-(propan-2-yl)-9,10-didehydroergoline-8β-carboxamide |
| 給藥途徑 | 口服給藥[1][2][3] |
| 藥物類別 | Serotonergic psychedelic; Hallucinogen |
| ATC碼 |
|
| 識別資訊 | |
| |
| CAS號 | 3028950-74-2 |
| PubChem CID | |
| ChemSpider | |
| 化學資訊 | |
| 化學式 | C24H29N3O2 |
| 摩爾質量 | 391.52 g·mol−1 |
| 3D模型(JSmol) | |
| |
| |
1cP-LSD(或稱為:1-環丙甲醯基-MIPLA,1-cyclopropanoyl-MIPLA,或1-環丙甲醯基-N-甲基-N-異丙基麥角醯胺,1-cyclopropanoyl-N-methyl-N-isopropyllysergamide)是一種有機化合物,化學式為C24H29N3O2,為麥角酸二乙醯胺(LSD)衍生物[1][2],最早在日本被發現[3]。
參考文獻
[編輯]- ^ 1.0 1.1 1cP-MIPLA. АИПСИН. [26 July 2025] (俄語).
- ^ 2.0 2.1 Tanaka R, Kawamura M, Mizutani S, Kikura-Hanajiri R. Analyses of LSD analogs in illegal products: The identification of 1cP-AL-LAD, 1cP-MIPLA and 1V-LSD. Toxicologie Analytique et Clinique. 2022, 34 (3): S171. Bibcode:2022ToxAC..34Q.171T. doi:10.1016/j.toxac.2022.06.295
.
- ^ 3.0 3.1 Tanaka R, Kawamura M, Mizutani S, Kikura-Hanajiri R. Identification of LSD analogs, 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD and LSZ in sheet products (PDF). Forensic Toxicology. 2023, 41 (2): 294–303 [26 July 2025]. ISSN 1860-8965. PMC 10310582
. PMID 36809464. doi:10.1007/s11419-023-00661-1
.